Search Results

He is particularly excited by the novel application of PAMs in chronic and neuropathic pain models , including the neuroma model , which is typically opioid-insensitive. Discovering breakthrough results in neuroma pain models via a spontaneous collaboration. This project involves molecular pharmacology in cell models to determine binding sites and mechanisms of allostery, as well as efficacy studies in mouse and rat models of acute and chronic pain.

Alex Serafini shares why pain research must start with real-world behavior and models before drilling , Serafini’s vision is bold: build a lab that develops translational models of pain rooted in patient He's equally focused on sex differences in pain processing and the failure of "one-size-fits-all" models Whether it’s challenging legacy targets, redefining preclinical models, or exploring the epigenetic inheritance He aspires to become a physician-scientist, with a focus on translational in vitro and in vivo model

Biotech founder Ajay Yekkirala shares how AI, GPCRs, and bold questions are driving next-gen pain therapeutics interested in translational innovation Biotech investors and strategic leaders seeking new drug development models Woolf at Boston Children’s Hospital and Harvard Medical School, where he deepened his understanding of pain Driven by the opioid crisis and the lack of non-addictive pain treatments, Ajay co-founded Blue Therapeutics , a biotech startup focused on targeting supraspinal GPCRs for chronic pain.

GPCR Title: Modeling Cardiac Fibrosis in a Dish: Combining hIPSC-Derived Fibroblasts and FRET Biosensors GPCR Title: Characterization of Novel Opioid-Neurotensin Bifunctional Ligands Designed to Target Pain interested in characterizing novel G protein-coupled receptors (GPCRs) ligands for the treatment of chronic pain

During these four sessions, you'll dive into: Advanced pharmacokinetic modeling The Druglike Quality Model to Predict Agonism – October 2, 2025 Premium Members save 25% on enrollment. Classified GPCR News Let’s dive into the Classified GPCR News from February 10th to 16th, 2025 Industry News Pain administration in spinal cord injury GPR37L1 identifies spinal cord astrocytes and protects neuropathic pain Neuroregeneration , EPSC , GLT-1 , GPR37L1 , SPM , astrocytes , maresin 1 , microglia , nerve injury , neuropathic pain

Her next career step took her to AstraZeneca as a postdoctoral trainee, where she studied animal models of pain and sensory neuron sensitive-receptor. Andrew Charles that who specialized in animal models of migraine and delta-opioid receptors as a therapeutic

published seminal papers where he used various approaches to describe the role of opioid receptors in pain Dr Gendron is co-director of the FRQS-funded Quebec Pain Research Network and the Editor-in-Chief in

From her early doubts to designing preclinical models of fentanyl and xylazine overdose, she reflects The methods used to measure respiratory depression in live models. But loss has a way of sharpening focus—friends lost to overdose brought the opioid epidemic into painful shut down breathing through different mechanisms—work that blends receptor pharmacology, preclinical models

conjugates to target GPCRs, with a focus on receptors relevant for treating osteoporosis, diabetes, and pain During that time, I investigated the effect of lung cancer-related mutations in the GAIN domain of the elucidating the molecular basis of membrane protein signalling using quantitative assays and molecular modelling

biased agonism, and incorporates computational and mathematical modelling, structural and chemical biology , molecular and cellular pharmacology, medicinal chemistry, and preclinical models of behaviour and disease encompassing neurological and psychiatric disorders, cardiovascular disease, obesity, diabetes, chronic pain The conversation ended with Arthur's ongoing research and his development of a new operational model. model for allosteric modulation, emphasizing the balance between mechanism and empiricism.

of opioid receptors and is currently focusing on the pharmacology of cannabinoids in the context of pain

Nigel Bunnett at the NYU Pain Research Center as a postdoctoral researcher. focuses on investigating GPCR signaling and trafficking in the context of inflammation and chronic pain Next Steps Badr will continue focusing his research on GPCRs involved in pain and inflammation during Badr shared his passion for GPCR signalling and regulation, specifically in the context of pain and inflammation

Can models predict drug outcomes? Jens Carlsson shares how GPCR modeling is moving from explanation to real prediction in drug discovery . << Back to podcast list Strategic Partner(s) Model. Jens Carlsson What if models didn’t just explain the past — but could truly predict what comes next? Yamina Berchiche to share his unconventional journey from aspiring engineer to GPCR modeler.

characterization of the pharmacological properties of cannabinoids in conjunction with terpenes for pain

GPCR Retreat Program < Back to schedule Biased agonism at the GLP-1 receptor: from structure to animal models

Cancer Research, 2014) and GPCRs (Feigin, et al., PNAS, 2014) in breast cancer pathogenesis, using mouse models Mike also spoke about his initial struggles during his Ph.D., such as a difficult model system and a about cancer biology led him to transition into using mouse models. asked about his move from in vitro to in vivo work, and Mike explained that he wanted to use better models Yamina proposed further exploration of dosage and length of treatment in a mouse model and suggested

conjugates to target GPCRs, with a focus on receptors relevant for treating osteoporosis, diabetes, and pain

effects of missense lung cancer-mutations in the G-protein-coupled receptor Autoproteolysis-Inducing (GAIN the molecular mechanisms of adhesion GPCRs (aGPCRs) in lymphatic endothelial cells (LECs), a cellular model

neurons), Vollum Institute Portland (visiting scientist with Ed McCleskey, sensory neuron properties); Pain

Our first main research aspect is the identification of endogenous ligand of GPCRs. Our second main research aspect is dissecting the molecular mechanism underlying sensation of force, Our third main research aspect is working mechanism of GPCR. For arrestin mediated biased signaling, we have proposed the “flute model” and “poly proline region docking Our fourth main research aspect is ligand coding mechanisms and structural aided drug discovery of GPCR

Committee Sponsors GPCR Retreat Program < Back to schedule Pharmacological and Genetic Preclinical Models

Terry Kenakin’s unique course, Development of GPCR Ligands as Therapeutic Drugs , and gain essential April 1 - 3, 2025 | 2nd Peptide-Based Therapeutics Summit - USA April 2 - 3, 2025 | New therapeutic modalities larval growth and embryonic development in the multivoltine strain of Bombyx more Profiling Allosteric Modulators GPCRs in Neuroscience Cortical astrocyte activation triggers meningeal nociception and migraine-like pain β-arrestin-1/endothelin axis in human ovarian fibroblasts Methods & Updates in GPCR Research Histamine-modulated

Each session explores mechanistic models, translational challenges, and real-world therapeutic implications These GPCR webinars focus on conceptual frameworks, models, and translational insight that apply across Topics may include: • Receptor efficacy and operational models • Allosteric modulators (PAMs and NAMs ) • Biased agonism • Dose–response modeling • Calcium and signaling assays • Drug–receptor kinetics • They provide exposure to current thinking, advanced modeling approaches, and expert interpretation of

Full Agenda Session V Structural mechanisms of AGPCR signaling and function Structural Determinants Of GAIN Receptors Fabian Pohl Structural studies of the CELSR1 extracellular region reveal a compact multidomain module within the structure and hints at a model where the compact module could be pulled apart by robust mechanical -GAIN module regulates signaling. We present a two-step GPS cleavage model and respective determinants of the reaction."

passion, I recently started a postdoctoral fellowship to study the role of GPCRs in the mechanisms of pain

Before focusing on the development of innovative mathematical modeling and simulation methods for drug They explored the potential of merging mathematical models with biology, the complexities of GPCRs within Integrating Mathematical Models and Biology: A Fascinating Discussion Yamina and Aurelien Rizk had a conversation about the importance of merging mathematical models and biology. and relevance of mathematical models in systems biology and pharmacology.

For this, we have worked in three main areas: the regulation of G protein-coupled receptor signaling including structural biology and proteomics, molecular biology and biochemical enzymology, primary and model cell culture, and transgenic, knockout, knock-in and conditional models of mouse physiology and behavior

For this, we have worked in three main areas: the regulation of G protein-coupled receptor signaling including structural biology and proteomics, molecular biology and biochemical enzymology, primary and model cell culture, and transgenic, knockout, knock-in and conditional models of mouse physiology and behavior

For this, we have worked in three main areas: the regulation of G protein-coupled receptor signaling including structural biology and proteomics, molecular biology and biochemical enzymology, primary and model cell culture, and transgenic, knockout, knock-in and conditional models of mouse physiology and behavior

For this, we have worked in three main areas: the regulation of G protein-coupled receptor signaling including structural biology and proteomics, molecular biology and biochemical enzymology, primary and model cell culture, and transgenic, knockout, knock-in and conditional models of mouse physiology and behavior